To evaluate the safety, efficacy and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with incisional wounds
This is primarily a safety study to evaluate the safety of AIV001 when administered near incisional wounds. A unique model was used to assess incisional scarring, safety and biomarker assessments. Women electing to have the abdominoplasty procedure were enrolled in the study and abdominal incisions were generated on the abdominal skin. Up to 10 incisions were made on abdominal skn and treated as assigned. And data collection was conducted up to day 49 when the subjects were exited from the study and the abdominoplasty procedure performed. Exploratory efficacy measures were collected and pharmacokinetic profiles determined.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
16
Intradermal injection
Kaufman and Davis Plastic Surgery
Folsom, California, United States
Cosmetic Laser Dermatology
San Diego, California, United States
Adverse events
Local and systemic adverse events
Time frame: Day 1 through Day 49
Efficacy using Patient and Observer Scar Assessment Scale (6 parameters, 1 normal to 10 worst imaginable)
Evaluation of the healing of the wounds
Time frame: Day 7 through 49
Modified Vancouver Scar Scale (4 parameters, 0 = normal to 3 or 4 = severe)
Evaluation of the healing wounds
Time frame: Day 7 through 49
100 mm Visual Analogue Scale (0 = normal to 10 = poor scar)
Evaluation of healing wounds
Time frame: Day 7 through 49
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.